Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry
Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry
复制标题
DOI：
10.1136/bmj.313.7048.33
复制
发表时间：
1996-07-06
影响因子：
--
通讯作者：
Freemantle, N
中科院分区：
文献类型：
--
作者：
Bloor, K;Maynard, A;Freemantle, N
这是三份审查控制药物支出和提高药物使用效率的国际政策的文件中的第三份。本文回顾了管制药品供应的政策，特别是许可证和报销控制，价格和利润管制。价格和利润控制对提高药物使用的成本效益几乎没有激励作用，而是侧重于控制成本和国内产业的盈利能力。仔细监测的经济评估可以提高效率，改善患者和医疗保健系统的利益。
This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.